Eosinophilic esophagitis (EoE) and other eosinophilic GI disorders are increasingly recognized and diagnosed. The 12th edition provides on these conditions, covering the latest diagnostic criteria, dietary therapies, topical steroids, and emerging biologic treatments.

is not just a textbook. It is a living, breathing compendium of the absolute latest in digestive health. It is "hot" because it solves real clinical dilemmas you faced yesterday and prepares you for the technology you will use tomorrow.

For over 50 years, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease has been the gold standard for medical professionals in the field. The newly released continues this legacy, offering a comprehensive, two-volume masterwork that covers the latest advancements in pathophysiology, diagnosis, and patient management. Key Features of the 12th Edition

: Contributions from hundreds of global leaders in the field.

When a textbook reaches its 12th edition, the risk of staleness is real. However, the editorial team—led by Dr. Mark Feldman, Dr. Lawrence S. Friedman, and Dr. Lawrence J. Brandt—has done something remarkable. They have turned up the heat on innovation.

Read an expert summary highlighting the clinical and educational value of this classic text on the Gastroenterology Journal Website .

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

For GI fellows, practicing physicians, and multidisciplinary care teams, keeping up with this text is essential to maintaining an evidence-based clinical practice. This extensive review dives deep into why the 12th edition is a "hot" topic, what new chapters have been introduced, and how it transforms patient management. Why the 12th Edition is Trending

– Recognizing the complex interplay between GI malignancies and systemic involvement, this new section offers a multidisciplinary approach to managing advanced and metastatic disease.

The 12th edition captures all of these seismic shifts. If you are still relying on the previous edition, you are missing critical information that directly impacts patient care. The new team of editors has been carefully selected precisely to bridge the gap between traditional GI/hepatology knowledge and the innovations of the 2020s.